BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34859308)

  • 1. Safety and Efficacy of Microwave Ablation for Hepatocellular Carcinoma in the Setting of Transjugular Intrahepatic Portosystemic Shunt.
    Yan J; Ying X; Malhotra A; Talenfeld A; Charalel R; Lee KS; Trost D; Kesselman A
    Cardiovasc Intervent Radiol; 2022 May; 45(5):578-581. PubMed ID: 34859308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma in Patients with Transjugular Intrahepatic Portosystemic Shunts.
    Park JK; Al-Tariq QZ; Zaw TM; Raman SS; Lu DS
    Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1211-7. PubMed ID: 25670215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
    Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
    Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma.
    Balducci D; Montori M; De Blasio F; Di Bucchianico A; Argenziano ME; Baroni GS; Scarpellini E
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Analysis of Safety and Efficacy of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma in Patients with and without Pre-Existing Transjugular Intrahepatic Portosystemic Shunts.
    Ruohoniemi DM; Taslakian B; Aaltonen EA; Hickey R; Patel A; Horn JC; Chiarello M; McDermott M
    J Vasc Interv Radiol; 2020 Mar; 31(3):409-415. PubMed ID: 31982313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the risk factors of hepatocellular carcinoma and survival analysis for cirrhosis after transjugular intrahepatic portosystemic shunt in treating portal hypertension.
    Wei J; Li H; Li C
    J Cancer Res Ther; 2018; 14(4):826-832. PubMed ID: 29970660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Locoregional Tumor Therapy for Patients with Hepatocellular Carcinoma and Transjugular Intrahepatic Portosystemic Shunts.
    Padia SA; Chewning RH; Kogut MJ; Ingraham CR; Johnson GE; Bhattacharya R; Kwan SW; Monsky WL; Vaidya S; Hippe DS; Valji K
    Cardiovasc Intervent Radiol; 2015 Aug; 38(4):913-21. PubMed ID: 25373795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
    Qiu B; Li K; Dong X; Liu FQ
    Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1372-1382. PubMed ID: 28488102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis.
    Zhao JB; Feng C; Zhu QH; He XF; Li YH; Chen Y
    World J Gastroenterol; 2014 Feb; 20(6):1602-7. PubMed ID: 24587637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt occlusion via modified pringle maneuver for radiofrequency ablation of nearby tumor.
    Pua U; Punamiya S
    J Vasc Interv Radiol; 2012 Apr; 23(4):563-5. PubMed ID: 22464718
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and Efficacy of Segmental Yttrium-90 Radioembolization for Hepatocellular Carcinoma after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Gordon AC; Gupta AN; Gabr A; Thornburg BG; Kulik LM; Ganger DR; Maddur H; Flamm SL; Boike JR; Moore CM; Borja-Cacho D; Christopher DA; Katariya NN; Ladner DP; Caicedo-Ramirez JC; Riaz A; Salem R; Lewandowski RJ
    J Vasc Interv Radiol; 2021 Feb; 32(2):211-219. PubMed ID: 33349507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt.
    Lu HL; Xuan FF; Luo YC; Qin X
    Abdom Radiol (NY); 2021 Nov; 46(11):5417-5427. PubMed ID: 34302511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft.
    Pua U
    Korean J Radiol; 2014; 15(1):181. PubMed ID: 24497813
    [No Abstract]   [Full Text] [Related]  

  • 16. Transjugular Intrahepatic Portosystemic Shunt Creation in Patients with Hepatocellular Carcinoma and Bleeding Gastric Varices: More Data, More Questions.
    Shah KY; Gaba RC
    J Vasc Interv Radiol; 2021 Jul; 32(7):971-973. PubMed ID: 34210483
    [No Abstract]   [Full Text] [Related]  

  • 17. Occult Hepatocellular Carcinoma Associated With Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients.
    Krumeich LN; Mancinelli J; Cucchiara A; Eddinger K; Aufhauser D; Goldberg DW; Siegelman ES; Rosen M; Reddy KR; Hoteit M; Furth EE; Olthoff KM; Shaked A; Levine M; Abt P
    Liver Transpl; 2021 Sep; 27(9):1248-1261. PubMed ID: 33853207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
    Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH
    Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a long-term follow-up.
    Huang S; Yu J; Liang P; Yu X; Cheng Z; Han Z; Li Q
    Eur J Radiol; 2014 Mar; 83(3):552-8. PubMed ID: 24418287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: safety and efficacy of high-power microwave platforms.
    Filippiadis DK; Spiliopoulos S; Konstantos C; Reppas L; Kelekis A; Brountzos E; Kelekis N
    Int J Hyperthermia; 2018 Sep; 34(6):863-869. PubMed ID: 28828899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.